In summary, overexpression of the GSK3β, β-Catenin, STAT3, and CD44 oncogenes and downregulation of the miR-135b tumor suppressor in GBM tumor samples compared to adjacent normal tissue were associated with poor patient prognoses, stemness, and therapeutic resistance. The gene discussed is CD44; the disease is glioblastoma.